These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9714674)

  • 1. Genetic medicine--when will it come to the drugstore?
    Wittung-Stafshede P
    Science; 1998 Jul; 281(5377):657-8. PubMed ID: 9714674
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acid therapeutics: state of the art and future prospects.
    Gewirtz AM; Sokol DL; Ratajczak MZ
    Blood; 1998 Aug; 92(3):712-36. PubMed ID: 9680338
    [No Abstract]   [Full Text] [Related]  

  • 3. Antisense oligonucleotides in lung cancer.
    Pujol JL; Jacot W
    Suppl Tumori; 2002; 1(4):S50-1. PubMed ID: 12415820
    [No Abstract]   [Full Text] [Related]  

  • 4. Sense antisense nonantisense. Can these novel antivirals knock HIV senseless?
    Chang HE; Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):11-8. PubMed ID: 11362229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Bcl-2 protein expression in solid tumors and hematologic malignancies with antisense oligonucleotides.
    Tolcher AW
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):635-42, 662. PubMed ID: 16167050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.
    AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials referral resource. Current clinical trials of G3139.
    Tock B; Zwiebel JA; Schoenfeldt M
    Oncology (Williston Park); 2003 Sep; 17(9):1244-6, 1251-3, 1258. PubMed ID: 14569852
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in antisense therapeutics discovery and development.
    Crooke ST
    Ciba Found Symp; 1997; 209():158-64; discussion 164-8. PubMed ID: 9383575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of progress in antisense therapeutics.
    Crooke ST
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):115-22. PubMed ID: 9593049
    [No Abstract]   [Full Text] [Related]  

  • 11. Crohn's trial shows the pros of antisense.
    Robertson D
    Nat Biotechnol; 1997 Mar; 15(3):209. PubMed ID: 9062911
    [No Abstract]   [Full Text] [Related]  

  • 12. Triplex forming oligonucleotides--tool for gene targeting.
    Mojzísek M
    Acta Medica (Hradec Kralove); 2004; 47(3):151-6. PubMed ID: 15568730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Bcl2 therapy in chronic myelogenous leukemia.
    Smith S
    Leuk Lymphoma; 2008 Jul; 49(7):1232-3. PubMed ID: 18604712
    [No Abstract]   [Full Text] [Related]  

  • 14. Antisense therapy in oncology: new hope for an old idea?
    Tamm I; Dörken B; Hartmann G
    Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genta initiates trials with Genasense.
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):6. PubMed ID: 12113068
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of therapeutic oligonucleotides.
    Diasio RB; Zhang R
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):239-43. PubMed ID: 9212918
    [No Abstract]   [Full Text] [Related]  

  • 17. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense has growing pains.
    Gura T
    Science; 1995 Oct; 270(5236):575-7. PubMed ID: 7570012
    [No Abstract]   [Full Text] [Related]  

  • 19. Antisense effects in the cell nucleus: modification of splicing.
    Kole R; Sazani P
    Curr Opin Mol Ther; 2001 Jun; 3(3):229-34. PubMed ID: 11497345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment for Crohn's disease.
    Yacyshyn BR
    Lancet; 1998 Aug; 352(9129):743. PubMed ID: 9729027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.